These Terms of Use (“Terms”) govern participation in the closed beta test (“Closed Beta Test” or “CBT”) of the product currently identified as the “ActEngine” (the “Product”), owned and made available by LINE Plus Corporation (“Company,” “we,” “us,” or “our”) to the business entity or individual identified in the applicable order form, onboarding form, or sign-up process (“Participant,” “Business Owner,” “you,” or “your”). The Product will be deployed on Participant's own website, mobile application, or live LINE Official Account (“OA”) for the duration of the CBT Period. By accessing, installing, configuring, or otherwise using the Product during the Closed Beta Test, Participant agrees to be bound by these Terms. If Participant does not agree to these Terms, Participant must not access or use the Product.
1. Nature of the Closed Beta Test
The Product is made available solely for the purpose of evaluation, testing, and feedback during a limited, invitation-only closed beta period (“CBT Period”). The Product is a pre-release, non-final version of a product under active development. Although the Product will operate on Participant's actual, live OA and may interact with Participant's real customers during the CBT Period, the Product itself remains an unfinished, evolving version and is not represented as a finalized commercial release. The CBT Period shall commence on the date Company enables Participant's access to the Product expected in August - September 2026 and is expected to continue for approximately two (2) to three (3) weeks, unless the commencement or end of the CBT period is otherwise determined, or the CBT Period is earlier terminated or extended, by Company in its sole discretion.
The Product, including all features, functions, outputs, integrations, and configurations (collectively, “Features”), is provided free of charge on an experimental, evolving, and non-final basis. Features may be added, removed, modified, restricted, disabled, or discontinued at any time, with or without notice to Participant.
2. No Warranty; No Representation as to Accuracy or Fitness
THE PRODUCT IS PROVIDED “AS IS” AND “AS AVAILABLE,” WITHOUT WARRANTY OF ANY KIND, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHERWISE, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ACCURACY, RELIABILITY, OR AVAILABILITY.
Without limiting the foregoing, Company makes no representation, warranty, or guarantee that: (a) any Feature will function accurately, consistently, or as described in any documentation, demonstration, or communication; (b) any output, response, recommendation, or action generated or taken by the Product (including any AI-generated content, decision, or automated response) will be correct, complete, appropriate, or suitable for any particular use case; (c) the Product will operate without interruption, error, or defect; or (d) any defect, inaccuracy, or malfunction identified during the CBT will be corrected within any particular timeframe or at all.
Participant acknowledges that the Product is being tested precisely because its Features, accuracy, and behavior are unverified, and that Participant's use of the Product is undertaken with full knowledge of this experimental status.
3. Allocation of Risk and Business Responsibility
Participant is solely and exclusively responsible for any and all decisions to deploy, integrate, configure, or rely upon the Product, or any output of the Product, in connection with Participant's business operations, customer-facing services, or any other commercial activity (“Participant's Business Use”).
Participant shall use the Product only for lawful purposes and in accordance with these Terms. Participant shall not misuse the Product, attempt to circumvent its safeguards or technical restrictions, or use the Product in any manner that may harm the Product, Company, or any third party. Participant remains solely responsible for reviewing and validating any AI-generated output before relying on or communicating such output to its customers, end users, or other third parties.
AS BETWEEN THE PARTIES, PARTICIPANT (AS THE BUSINESS OWNER) BEARS SOLE AND EXCLUSIVE RESPONSIBILITY AND LIABILITY FOR ANY BUSINESS IMPACT, LOSS, DAMAGE, LIABILITY, CLAIM, OR ADVERSE CONSEQUENCE OF ANY KIND ARISING OUT OF OR IN CONNECTION WITH PARTICIPANT'S BUSINESS USE OF THE PRODUCT DURING THE CBT PERIOD, INCLUDING WITHOUT LIMITATION ANY LOSS OF REVENUE, LOSS OF DATA, LOSS OF CUSTOMERS OR CUSTOMER GOODWILL, SERVICE DISRUPTION, INCORRECT OR INAPPROPRIATE AI-GENERATED OUTPUT, OR ANY THIRD-PARTY CLAIM.
Company shall have no liability whatsoever for any such business impact, loss, or damage. Participant assumes full responsibility for implementing appropriate safeguards, human oversight, escalation procedures, and contingency measures before relying on the Product in any live, customer-facing, or otherwise consequential business context.
Nothing in these Terms shall be construed as Company providing any assurance, undertaking, or guarantee regarding the commercial, operational, or financial outcomes of Participant's Business Use of the Product.
4. Relationship to the LINE Official Account Platform
If applicable, Participant's use of the underlying LINE Official Account platform (as distinct from the Product itself) remains separately subject to the LINE Official Account Terms of Use and related policies applicable to Participant's OA, which Participant is responsible for complying with independently of these Terms. These Terms govern only the Product (the ActEngine) and Participant's participation in the CBT, and do not modify or supersede the separate terms governing Participant's OA generally. Participant is solely responsible for providing any notices or obtaining any consents required under applicable law in connection with its use of the Product.
Where the Product's Features or outputs are delivered to Participant's end customers through the OA messaging interface, Section 3 above governs allocation of responsibility for such Features and outputs; this Section 4 addresses only the separate, underlying OA platform terms.
5. Limitation of Liability
TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL COMPANY BE LIABLE TO PARTICIPANT FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, EXEMPLARY, OR PUNITIVE DAMAGES, OR FOR ANY LOSS OF PROFITS, REVENUE, DATA, OR BUSINESS OPPORTUNITY, ARISING OUT OF OR RELATING TO THE CBT OR THE PRODUCT, REGARDLESS OF THE THEORY OF LIABILITY AND EVEN IF COMPANY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
6. Feedback, Confidentiality and Use of Information
Participant may provide feedback, bug reports, suggestions, or other input regarding the Product (“Feedback”). Participant grants Company a non-exclusive, perpetual, irrevocable, royalty-free license to use such Feedback for any purpose, including improving the Product, without any obligation or compensation to Participant.
Participant shall keep confidential all non-public information relating to the Product, including its existence, Features, performance, and any materials provided by Company in connection with the CBT, and shall not disclose such information to any third party without Company's prior written consent, except as required by law.
Participant shall not publish or disclose any benchmark results, performance evaluations, or other non-public information relating to the Product without Company's prior written consent.
LINE has right to use the information (except for personal information) related to this CBT such as campaign performance for our development and external communication for PR purpose in any form (offline/online) including in sales deck or presentation and in any territory without any consideration and time-limitation.
7. Term and Termination
These Terms commence upon Participant's first access to the Product and continue until the earlier of (a) the end of the CBT Period as notified by Company, or (b) termination in accordance with this Section 7.
Company may suspend or terminate Participant's access to the Product, in whole or in part, at any time and for any reason, including discontinuation of the CBT, without liability to Participant.
Upon termination, Participant shall immediately cease all use of the Product and, if requested, destroy or return any related materials.
Upon expiration or termination of the CBT Period, Company may deactivate or close Participant's account and discontinue Participant's access to the Product. Company shall have no obligation to maintain or continue any functionality of or access to, the Product after the CBT Period. Any continued technical availability of all or any part of the Product after the end of the CBT Period shall not constitute an extension or renewal of the CBT or grant any Participant's any right to use or continue to access the Product.
Notwithstanding any opt-out, expiration, or termination of these Terms, participant’s obligations under Section 6 (Feedback, Confidentiality and Use of Information) and any accrued rights, obligations, or liabilities arising from Participant’s use of the Product prior to deactivation shall remain in full force and effect.
8. Data and Privacy
Any personal data processed through the Product during the CBT shall be handled in accordance with Company's applicable privacy notice and personal data protection policy, as provided to Participant separately, and in accordance with applicable data protection law. Participant is responsible for ensuring it has an appropriate legal basis to submit any personal data of its own customers or end-users into the Product during the CBT.
9. General
The Product is subject to the Terms of Service issued by Line Plus Corporation ("Main Terms"). These Terms supplement the Main Terms solely with respect to the Participant's participation in the CBT conducted by us. In the event of any inconsistency, these Terms shall prevail only to the extent of matters relating specifically to the CBT.
These Terms constitute the entire agreement between Participant and Company with respect to the CBT and supersede all prior discussions or agreements on the subject matter, except as otherwise set out in a separate signed agreement between the parties.
Company may amend these Terms at any time by providing notice to Participant; continued use of the Product following such notice constitutes acceptance of the amended Terms.
These Terms shall be governed by and construed in accordance with the laws of Thailand, without regard to its conflict of laws principles. Any dispute arising out of or relating to these Terms shall be subject to the exclusive jurisdiction of the courts of Thailand.
If any provision of these Terms is held invalid or unenforceable, the remaining provisions shall continue in full force and effect.
These Terms may be generated, executed and kept as an electronic document as if it was generated, executed and kept in a paper form. Such electronic documents shall be valid and enforceable provided that it complies with the requirements under applicable law. You agree and accept that the acceptance of these Terms may be executed via email to LINE, including the sending of electronic messages from corporate email address, shall be valid and legally binding upon Participant and Participant shall not deny the validity and enforceability of these Terms. Participant shall be bound by any performance or activity by their staff, employee, or agency, that confirms the acceptance of and/or that sends electronic messages/documents to LINE.
10. Opt-Out
Participant may opt out of its participation in the CBT at any time by providing written notice (including via email) to the Company. Such opting out shall not constitute a breach of these Terms.
ACKNOWLEDGEMENT: By accessing or using the Product during the Closed Beta Test, Participant confirms that it has read, understood, and agrees to be bound by these Terms, including the disclaimers of accuracy set out in Section 2 and the allocation of business risk set out in Section 3.